Improved Bioavailability of Montelukast through a Novel Oral Mucoadhesive Film in Humans and Mice
The leukotriene receptor antagonist Montelukast (MTK) is an approved medication for the treatment of asthma and allergic rhinitis. The existing marketed tablet forms of MTK exhibit inconsistent uptake and bioavailability, which partially explains the presence of a significant proportion of MTK low-...
Saved in:
Main Authors: | Johanna Michael (Author), Diana Bessa de Sousa (Author), Justin Conway (Author), Erick Gonzalez-Labrada (Author), Rodolphe Obeid (Author), Julia Tevini (Author), Thomas Felder (Author), Birgit Hutter-Paier (Author), Horst Zerbe (Author), Nadine Paiement (Author), Ludwig Aigner (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The leukotriene receptor antagonist montelukast as a potential therapeutic adjuvant in multiple sclerosis - a review
by: Frank Pietrantonio, et al.
Published: (2024) -
Current Approaches to Use Cyclodextrins and Mucoadhesive Polymers in Ocular Drug Delivery-A Mini-Review
by: Tivadar Bíró, et al.
Published: (2019) -
Mucoadhesive In Situ Rectal Gel Loaded with Rifampicin: Strategy to Improve Bioavailability and Alleviate Liver Toxicity
by: Fakhria Al-Joufi, et al.
Published: (2021) -
MONTELUKAST IN TREATING ALLERGIC DISEASES
by: T.V. Kulichenko
Published: (2006) -
MONTELUKAST IN TREATING ALLERGIC DISEASES
by: T.V. Kulichenko
Published: (2006)